Aspiriant LLC’s iShares Russell Mid-Cap ETF IWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59M Sell
36,928
-2,397
-6% -$239K 0.1% 85
2025
Q4
$3.79M Buy
39,325
+14
+0% +$1.35K 0.11% 83
2025
Q3
$3.8M Sell
39,311
-39,597
-50% -$3.75M 0.12% 77
2025
Q2
$7.26M Buy
78,908
+39,454
+100% +$3.41M 0.23% 50
2025
Q1
$3.36M Hold
39,454
0.12% 71
2024
Q4
$3.49M Buy
39,454
+3,075
+8% +$279K 0.13% 69
2024
Q3
$3.21M Hold
36,379
0.12% 73
2024
Q2
$2.95M Sell
36,379
-176
-0.5% -$14.3K 0.12% 76
2024
Q1
$3.07M Sell
36,555
-1,820
-5% -$144K 0.13% 75
2023
Q4
$2.98M Hold
38,375
0.13% 72
2023
Q3
$2.66M Sell
38,375
-89
-0.2% -$6.49K 0.14% 74
2023
Q2
$2.81M Sell
38,464
-188
-0.5% -$13.1K 0.14% 72
2023
Q1
$2.7M Sell
38,652
-84
-0.2% -$5.93K 0.14% 75
2022
Q4
$2.61M Sell
38,736
-162
-0.4% -$10.9K 0.13% 73
2022
Q3
$2.42M Sell
38,898
-2,348
-6% -$162K 0.12% 73
2022
Q2
$2.67M Buy
41,246
+1,087
+3% +$77.4K 0.13% 71
2022
Q1
$3.13M Sell
40,159
-584
-1% -$45K 0.17% 66
2021
Q4
$3.38M Buy
40,743
+4,045
+11% +$332K 0.18% 64
2021
Q3
$2.87M Sell
36,698
-1,711
-4% -$137K 0.17% 65
2021
Q2
$3.04M Buy
38,409
+206
+0.5% +$16K 0.17% 60
2021
Q1
$2.82M Sell
38,203
-243
-0.6% -$17.6K 0.18% 55
2020
Q4
$2.63M Buy
38,446
+748
+2% +$47.6K 0.18% 55
2020
Q3
$2.16M Sell
37,698
-909
-2% -$51.7K 0.17% 66
2020
Q2
$2.07M Sell
38,607
-5,020
-12% -$252K 0.19% 54
2020
Q1
$1.88M Sell
43,627
-1,697
-4% -$93.4K 0.19% 51
2019
Q4
$2.7M Hold
45,324
0.25% 49
2019
Q3
$2.53M Sell
45,324
-5,024
-10% -$281K 0.23% 65
2019
Q2
$2.81M Sell
50,348
-903
-2% -$49.5K 0.23% 65
2019
Q1
$2.76M Sell
51,251
-8,999
-15% -$466K 0.23% 68
2018
Q4
$2.8M Sell
60,250
-4,310
-7% -$217K 0.21% 67
2018
Q3
$3.56M Sell
64,560
-800
-1% -$43.8K 0.3% 54
2018
Q2
$3.47M Sell
65,360
-2,092
-3% -$110K 0.3% 56
2018
Q1
$3.48M Buy
67,452
+52,672
+356% +$2.78M 0.3% 52
2017
Q4
$769K Sell
14,780
-64,052
-81% -$3.25M 0.23% 40
2017
Q3
$3.88M Sell
78,832
-11,180
-12% -$540K 0.33% 47
2017
Q2
$4.32M Sell
90,012
-3,040
-3% -$144K 0.38% 45
2017
Q1
$4.35M Sell
93,052
-2,232
-2% -$103K 0.37% 46
2016
Q4
$4.26M Sell
95,284
-2,000
-2% -$87.5K 0.39% 38
2016
Q3
$4.24M Sell
97,284
-7,472
-7% -$324K 0.42% 37
2016
Q2
$4.45M Sell
104,756
-1,000
-0.9% -$41.3K 0.42% 38
2016
Q1
$4.31M Buy
105,756
+83,936
+385% +$3.19M 0.41% 39
2015
Q4
$874K Buy
21,820
+4,144
+23% +$169K 0.1% 46
2015
Q3
$687K Buy
17,676
+676
+4% +$28K 0.06% 60
2015
Q2
$724K Hold
17,000
0.07% 59
2015
Q1
$736K Hold
17,000
0.1% 49
2014
Q4
$710K Hold
17,000
0.1% 49
2014
Q3
$673K Hold
17,000
0.09% 45
2014
Q2
$691K Hold
17,000
0.1% 55
2014
Q1
$658K Hold
17,000
0.1% 61
2013
Q4
$637K Buy
+17,000
New +$614K 0.1% 52
2013
Q3
Sell
-17,000
Closed -$552K 59
2013
Q2
$552K Buy
+17,000
New +$551K 0.09% 45

Other funds holding IWR

Aspiriant LLC's IWR Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares Russell Mid-Cap ETF (IWR) stake by 6.1% in Q1 2026, selling an estimated $239K and leaving 36,928 shares worth $3.59M. The position accounts for 0.1% of the portfolio, ranked #85.

Aspiriant LLC first reported a position in IWR in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.26M in Q2 2025. 1,514 funds tracked by Wall St. Rank hold IWR as of Q1 2026.

  • Aspiriant LLC held 36,928 shares of iShares Russell Mid-Cap ETF worth $3.59M as of Q1 2026.
  • Aspiriant LLC sold 2,397 iShares Russell Mid-Cap ETF shares in Q1 2026, an estimated $239K.
  • iShares Russell Mid-Cap ETF made up 0.1% of Aspiriant LLC's portfolio in Q1 2026, its #85 holding.
  • Aspiriant LLC first reported a position in iShares Russell Mid-Cap ETF in Q2 2013 and has held it in 51 quarters since.
  • Aspiriant LLC's iShares Russell Mid-Cap ETF position peaked at $7.26M in Q2 2025.
  • 1,514 funds tracked by Wall St. Rank held iShares Russell Mid-Cap ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.